project id: TCGA-LUAD; case submitter id: TCGA-NJ-A7XG; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; age at index: 49; days to birth: -18127; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1964; age at diagnosis: 18127; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 617.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 72; days to sample procurement: 0; initial weight: 140.0; portion submitter id: TCGA-NJ-A7XG-01A-12; percent lymphocyte infiltration: 6.0; percent monocyte infiltration: 1.0; percent necrosis: 2.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 73.0; percent tumor nuclei: 90.0;